Effects of combretastatin on murine tumours monitored by 31P MRS, 1H MRS and 1H MRI
- 1 November 1998
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 42 (4) , 891-894
- https://doi.org/10.1016/s0360-3016(98)00359-9
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Magnetic resonance imaging and spectroscopy of combretastatin A4 prodrug-induced disruption of tumour perfusion and energetic statusBritish Journal of Cancer, 1998
- Effects of blood flow modifiers on tumor metabolism observedin vivoby proton magnetic resonance spectroscopic imagingMagnetic Resonance in Medicine, 1996
- Anti—vascular approaches to solid tumour therapy: Evaluation of vinblastine and flavone acetic acidInternational Journal of Cancer, 1995
- The response of spontaneous and transplantable murine tumors to vasoactive agents measured by 31p magnetic resonance spectroscopyInternational Journal of Radiation Oncology*Biology*Physics, 1992
- In vivo targets of recombinant human tumour necrosis factor-α: blood flow, oxygen consumption and growth of isotransplanted rat tumoursBritish Journal of Cancer, 1989
- Vasoactive intestinal peptide stimulates glycolysis in pituitary tumours; 1H-NMR detection of lactate in vivoBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1988
- Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissueBritish Journal of Cancer, 1980